AURA vs LEN · $406.7M cap vs rev $34.19B
Aura Biosciences Inc (AURA) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Aura Biosciences Inc (AURA) is a biotechnology company listed on US.
LEN (LEN) common stock.
AURA does not have a complete income-statement cache yet.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
AURA currently screens at market cap $406.7M. LEN currently screens at market cap $0.
Not investment advice. Open the AURA and LEN stock pages for the full models.
Not investment advice.